Skip to main content
SpringerLink
Log in

Μultiple myeloma developing after imatinib mesylate therapy for chronic myeloid leukemia

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Nitta M, Tsuboi K, Yamasita S, Kato M, Hayami Y, Harada S et al (1999) Multiple myeloma preceding the development of chronic myelogenous leukemia. Int J Hematol 69:170–173

    PubMed  CAS  Google Scholar 

  2. Peggs K, Mackinnon S (2003) Imatinib mesylate—the new gold standard for treatment of chronic myeloid leukemia. N Engl J Med 348:1048–1050 doi:10.1056/NEJMe030009

    Article  PubMed  Google Scholar 

  3. Garipidou V, Vakalopoulou S, Tziomalos K (2005) Development of multiple myeloma in a patient with chronic myeloid leukemia after treatment with imatinib mesylate. Oncologist 10:457–458 doi:10.1634/theoncologist.10-6-457

    Article  PubMed  Google Scholar 

  4. Schwarzmeier JD, Shehata M, Ackermann J, Hilgarth M, Kaufmann H, Drach J (2003) Simultaneous occurrence of chronic myeloid leukemia and multiple myeloma: evaluation by FISH analysis and in vitro expansion of bone marrow cells. Leukemia 17:1426–1428 doi:10.1038/sj.leu.2402971

    Article  PubMed  CAS  Google Scholar 

  5. Pandiella A, Carvajal-Vergara X, Tabera S, Mateo G, Gutierrez N, San Miguel JF (2003) Imatinib mesylate (STI571) inhibits multiple myeloma cell proliferation and potentiates the effect of common antimyeloma agents. Br J Haematol 123:858–868 doi:10.1046/j.1365-2141.2003.04706.x

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Hematology, District General “G.Gennimatas” Hospital, 154 Mesogion street, 11527, Athens, Greece

    A. Galanopoulos & N. I. Anagnostopoulos

  2. Department of Laboratory Hematology, “G. Gennimatas” Hospital, Athens, Greece

    S. I. Papadhimitriou, E. Kritikou-Griva & M. Georgiakaki

Authors
  1. A. Galanopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. I. Papadhimitriou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Kritikou-Griva
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Georgiakaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. I. Anagnostopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Galanopoulos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Galanopoulos, A., Papadhimitriou, S.I., Kritikou-Griva, E. et al. Μultiple myeloma developing after imatinib mesylate therapy for chronic myeloid leukemia. Ann Hematol 88, 281–282 (2009). https://doi.org/10.1007/s00277-008-0597-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-008-0597-2

Keywords

Search

Navigation